THEMIS MEDICARE
Back to Cashflow Statement
|
THEMIS MEDICARE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-8.77 Cr | ₹0.14 Cr | ₹-18 Cr | ₹-26 Cr | ₹6.72 Cr |
What is the latest Cash Flow from Financing Activities ratio of THEMIS MEDICARE ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-8.77 Cr |
Mar2023 | ₹0.14 Cr |
Mar2022 | ₹-18 Cr |
Mar2021 | ₹-26 Cr |
Mar2020 | ₹6.72 Cr |
How is Cash Flow from Financing Activities of THEMIS MEDICARE Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-8.77 Cr | Negative | |
Mar2023 | ₹0.14 Cr | Positive | |
Mar2022 | ₹-18 Cr | Negative | |
Mar2021 | ₹-26 Cr | Negative | |
Mar2020 | ₹6.72 Cr | - |
Compare Cash Flow from Financing Activities of peers of THEMIS MEDICARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
THEMIS MEDICARE | ₹1,025.8 Cr | 8.6% | -10.3% | -50.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
THEMIS MEDICARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
THEMIS MEDICARE | 8.6% |
-10.3% |
-50.8% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses